Frimer M

No ORCID on file · 5 papers in corpus · active 2014-2023
2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1059228

Endometrial cancer is the most common gynecologic malignancy in the United States and is one of the few malignancies that had an increasing incidence and mortality rate over the last 10 years. Current research models fail to recapitulate ac…

2021
PloS one ·doi:10.1371/journal.pone.0259188

ObjectiveTo characterize the microbiota of postmenopausal women undergoing hysterectomy for endometrioid (EAC) or uterine serous cancers (USC) compared to controls with non-malignant conditions.MethodsEndometrial, cervicovaginal and anorect…

2020
Gynecologic oncology reports ·doi:10.1016/j.gore.2020.100579

ObjectivePrimary endometrioid adenocarcinoma of the cervix is a rare subtype of adenocarcinoma that has often been misclassified in the literature due to the lack of clear-cut diagnostic criteria. A new classification system has recently be…

2019
Gynecologic Oncology ·doi:10.1016/j.ygyno.2019.08.007

ObjectiveTo examine the association between ovarian conservation and oncologic outcome in surgically-treated young women with early-stage, low-grade endometrial cancer.MethodsThis multicenter retrospective study examined women aged <50 with…

2014
Gynecologic oncology case reports ·doi:10.1016/j.gynor.2014.04.005

•Two cases of large cervical mullerian adenosarcoma with sarcomatous overgrowth or heterologous elements and contrasting survival outcomes are reported.•When the diagnosis of mullerian adenosarcoma is uncertain or suspected, review of patho…